Company news

Starpharma Holdings Limited news in 2024

Starpharma Holdings Limited's news releases, calls and decks from 2024, newest first.

View company

SPL receives positive FDA feedback on DEP SN38 for PROC

December 18, 2024

AGM Chair's address and CEO's presentation

November 26, 2024

SPL7013 Nasal Spray Australia Update

October 17, 2024

Starpharma Receives $5.5M R&D Tax Incentive Refund

September 11, 2024

Annual Report to shareholders

August 21, 2024

Positive final DEP irinotecan Phase 2 clinical trial results

May 27, 2024

Starpharma Business Update

May 22, 2024

Starpharma and Medicxi Partnership Petalion Therapeutics

April 7, 2024

S&P DJI Announces March 2024 Quarterly Rebalance

March 1, 2024

VivaGel BV US FDA Appeal Outcome

February 18, 2024

Viraleze shows antiviral efficacy in COVID-19 patients

January 28, 2024

VivaGel BV sales and distribution agreement MENA region

January 22, 2024

Decks in 2024